Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0000950170-23-066394

Director acquired 2,857,142 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ellias Helen K. Director 2023-11-24 Option exercise +2,857,142 2,857,142 I: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ellias Helen K. Director 2023-11-24 Option exercise · Series A-1 Convertible Preferred Stock −1,800 $1,000.00 $1,800,000 0 I: show line 2 in the form
Loading xslF345X05/ownership.xml…